Ex parte KAO et al. - Page 7




            Appeal No. 96-3169                                                                 7              
            Application No. 08/271,273                                                                        


            that each of the process conditions required by the claimed subject matter may be                 
            present in the disclosure of Willemse or                                                          
            Volpenhein is not sufficient to establish inherency.  See In re Oelrich, 666 F.2d                 
            578, 581, 212 USPQ 323, 326 (CCPA 1981); Ex parte Skinner, 2 USPQ2d                               
            1788, 1789 (Bd. Pat. App. & Int. 1986).  Furthermore, the examiner must provide                   
            some evidence or scientific reasoning that the presence of the “combined level of                 
            difatty ketones and                                                                               
            $-ketoesters of about 300 ppm or less” characteristic is an inherent characteristic               
            of the prior art compositions.  In the case before us, no such evidence or reasoning              
            has been set forth.  Accordingly, the rejection of the examiner is reversed.                      
            Because we reverse on this basis, we need not reach the issue of the                              
            sufficiency of the showing of unexpected results.  In re Geiger, 815 F.2d 686,                    
            688, 2 USPQ2d 1276, 1278 (Fed. Cir. 1987).                                                        
                                                 DECISION                                                     
            The rejection of claims 1 through 4, 7, 9, 11, and 13 through 23 under 35                         
            U.S.C. § 103 as being unpatentable over Willemse is reversed.                                     
            The rejection of claims 1 through 4, 7, 9, 11, and 13 through 23 under 35                         
            U.S.C. § 103 as being unpatentable over Volpenhein is reversed.                                   
                                                                                                             






                                                      7                                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007